FDA
approval
· 2014-09-29
FDA Approved: VOLTAREN ARTHRITIS PAIN — Supplemental Application (Haleon US Holdings LLC)
Summary
The FDA approved a supplemental application to Voltaren Arthritis Pain (diclofenac sodium) to expand its labeling with a new indication for arthritis pain, unde…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VOLTAREN ARTHRITIS PAIN (DICLOFENAC SODIUM)